ClinConnect ClinConnect Logo
Search / Trial NCT05927363

Impact on Physical Activity of Coronary Patients in Phase 3 of a Therapeutic Consolidation Educational Program Involving a "Patient Partner" Associated With a Healthcare Professional.

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Jun 22, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Cardiovascular Rehabilitation Motivation Physical Activity

ClinConnect Summary

This clinical trial is studying how a special educational program can help patients who have had a heart attack (myocardial infarction) stay physically active after their initial rehabilitation. After a heart attack, patients often go through a rehabilitation process in three phases. The focus of this study is on the third phase, where the goal is to encourage patients to maintain a regular level of physical activity, as many tend to stop exercising after they finish the initial rehabilitation. The trial will compare a new program that includes support from a "patient partner" and a healthcare professional with usual care to see if it helps patients stay active.

To participate in this trial, individuals must be at least 18 years old, have recently completed the second phase of cardiac rehabilitation, and have access to a smartphone or similar device to communicate online. They also need to be fluent in French and give their consent to join. Participants will wear a device that tracks their physical activity for six months, helping researchers understand how effective the new program is in keeping patients active. It's important to note that those with serious health issues or conditions that prevent them from exercising cannot take part in this study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient of legal age (≥ 18 years).
  • Patient having undergone phase 2 treatment in the cardiovascular rehabilitation department of the CHU for myocardial infarction.
  • Patient with a means of communication that allows easy internet connection (i.e. a smartphone).
  • Patient fluent in French.
  • Patient who has given free informed consent.
  • Patient affiliated or beneficiary of a health insurance scheme.
  • Exclusion Criteria:
  • Patient with severe or unstable comorbidity (respiratory insufficiency renal failure, decompensated heart failure). heart failure).
  • Patient with unstable angina.
  • Patient with contraindications to physical activity following physical activity following cardiovascular rehabilitation (according to medical discussion, based on the recommendations of the French Society of Cardiology).
  • Patient with no suitable means of communication.
  • Patient under court protection, guardianship or curatorship.
  • Pregnant, parturient or breast-feeding patients.

About Centre Hospitalier Universitaire De Nīmes

The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.

Locations

Nimes, , France

Patients applied

0 patients applied

Trial Officials

Virginie VALLAYER

Principal Investigator

Nîmes University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported